Cullinan Oncology
CGEM
CGEM
98 hedge funds and large institutions have $466M invested in Cullinan Oncology in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+10
Holders Change %
+11.36%
% of All Funds
1.69%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
38
Reduced
28
Closed
8
Calls
$504K
Puts
$2K
Net Calls
+$502K
Net Calls Change
+$152K
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
$8.19M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
$7.18M |
| 3 |
CA
CHI Advisors
New York
|
$41.6M |
| 4 |
Goldman Sachs
New York
|
$4.19M |
| 5 |
BlackRock
New York
|
$30.4M |
